istock-506815322_artjazz

artjazz / iStockphoto.com

21 April 2022Alex Baldwin

Nagoya Protocol: ‘a masterpiece of ambiguity’

Since the Nagoya Protocol was implemented in October 2014, lawyers, academics, and the life sciences industry broadly have been calling upon institutions such as the European Union for guidance on how to best abide by the new regulations.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Benin accepts TRIPS protocol on affordable medicines

24 November 2016 Benin yesterday accepted the 2005 protocol amending the World Trade Organization’s (WTO) agreement on TRIPS, a protocol intended to ease poorer WTO members’ access to affordable medicines.

Genetics

Nagoya Protocol: searching for living gold

28 November 2014 Does the coming into force of the Nagoya Protocol represent an overdue step in the right direction towards fairness, or more red tape and unattainable expectations? Charles Brabin, a non-practising barrister, sifts through the complexities.

More on this story

Benin accepts TRIPS protocol on affordable medicines

24 November 2016 Benin yesterday accepted the 2005 protocol amending the World Trade Organization’s (WTO) agreement on TRIPS, a protocol intended to ease poorer WTO members’ access to affordable medicines.

Genetics

Nagoya Protocol: searching for living gold

28 November 2014 Does the coming into force of the Nagoya Protocol represent an overdue step in the right direction towards fairness, or more red tape and unattainable expectations? Charles Brabin, a non-practising barrister, sifts through the complexities.

More on this story

Benin accepts TRIPS protocol on affordable medicines

24 November 2016 Benin yesterday accepted the 2005 protocol amending the World Trade Organization’s (WTO) agreement on TRIPS, a protocol intended to ease poorer WTO members’ access to affordable medicines.

Genetics

Nagoya Protocol: searching for living gold

28 November 2014 Does the coming into force of the Nagoya Protocol represent an overdue step in the right direction towards fairness, or more red tape and unattainable expectations? Charles Brabin, a non-practising barrister, sifts through the complexities.

More features

China bars USPTO employee from leaving country

UPC hands rare default win to Insulet, bans insulin pump in EU

GSK loses appeal over purple inhaler TM in Europe

Astellas defends Xtandi patent as court rejects generics’ appeal

Jury sides with Allergan in $56M Botox tech feud

Novartis fails latest bid to block Entresto copies

BMS blocks biosimilar version of blockbuster cancer drug in India

WATCH: Protecting life science innovations involving big data, AI and machine learning